Sivan provides innovative digital therapeutic for the follow up of cancer patients. Sivan developed Moovcare®, the first application for early detection of relapses and complications in patients with lung cancer. Moovcare® is the first digital therapeutic officially reimbursed in France.



Our Representatives

Hemda Chen

Medical Director, Sivan Innovation

Medical Director

Sivan Innovation

Company Solutions

At a time when e-health and connected devices are anchored exponentially in the medical landscape, Sivan is a start up which aims to provide medical applications specially designed for the patients care, and to become a partner of the medical community. Sivan designs and develops innovative digital health solutions, which support healthcare professionals in their practice and care improvement, as well as patient’s QOL and life expectancy.

The story of Moovcare® started with the understanding of a French oncologist that realized that lung cancer patients were staying too long with the symptoms before they reported.

By the time they arrived at the scheduled medical visit, their health condition had deteriorated, and the treatment options were limited. This motivated him to develop an algorithm based on PRO tools to detect problems earlier.

Moovcare® is a digital therapy based on a smart algorithm that detects an anomaly and sends immediate alerts to the treating physician. Lung cancer patients are required to report their symptoms via a weekly digital questionnaire, and by that enable the oncologist to act immediately if needed. Thanks to Moovcare®, patients have constant communication with their physician, problems are detected earlier, and oncologists are giving the right treatment at the right time.

Moovcare® has an impact on the quality of life of patients and also helps reduce their anxiety by maintaining weekly contact with the care team. Moovcare® favorably modifies the workload of hospital teams while reducing the traditional care costs. Moovcare® is the first digital therapy officially reimbursed in France.

Looking For

Sivan has been working with leading clinicians to build devices that allow patients to easily monitor and report their symptoms, combined with disease specific algorithms that alert physicians when an anomaly is detected.

Sivan has a multidisciplinary team of clinicians, technologists and behavioural experts who have come together to solve some of the biggest challenges in healthcare.

Building on multi-year clinical studies on the impact of patient reported symptoms on survival and quality of life, carried out by leading oncologists in the US and France, Sivan has developed the first digital platform for the early detection of disease.